HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,899,076 | +8.9% | 25,059 | -3.2% | 0.00% | 0.0% |
| Q2 2023 | $2,661,348 | -26.4% | 25,876 | -18.6% | 0.00% | 0.0% |
| Q4 2022 | $3,616,109 | +119.3% | 31,776 | +19.3% | 0.00% | 0.0% |
| Q3 2022 | $1,649,000 | +8.1% | 26,643 | +39.3% | 0.00% | 0.0% |
| Q2 2022 | $1,525,000 | -32.6% | 19,122 | -11.1% | 0.00% | 0.0% |
| Q1 2022 | $2,263,000 | +76.8% | 21,510 | +81.1% | 0.00% | – |
| Q4 2021 | $1,280,000 | +10.8% | 11,876 | +12.7% | 0.00% | – |
| Q3 2021 | $1,155,000 | -41.7% | 10,541 | -50.1% | 0.00% | -100.0% |
| Q2 2021 | $1,980,000 | -3.8% | 21,140 | -5.4% | 0.00% | 0.0% |
| Q1 2021 | $2,058,000 | +29.5% | 22,357 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $1,589,000 | +5.1% | 21,722 | +11.6% | 0.00% | 0.0% |
| Q3 2020 | $1,512,000 | +18.5% | 19,461 | -15.2% | 0.00% | 0.0% |
| Q2 2020 | $1,276,000 | +394.6% | 22,954 | +221.1% | 0.00% | – |
| Q1 2020 | $258,000 | -26.9% | 7,149 | -26.6% | 0.00% | – |
| Q4 2019 | $353,000 | +46.5% | 9,742 | +2.9% | 0.00% | – |
| Q3 2019 | $241,000 | +8.1% | 9,466 | +2.0% | 0.00% | – |
| Q2 2019 | $223,000 | – | 9,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |